BackgroundThe prevalence of type 2 diabetes continues to rise in the United States and worldwide. Although novel pharmacotherapies have shown benefits, not all patients have access to these medicat…
BACKGROUND: Sustained pathological cardiac hypertrophy eventually leads to heart failure; however, there is currently no effective therapeutic approach. Epigenetic dysregulation, including histone modification alterations, is…
Ultraprocessed foods and beverages (UPFs) pose a growing public health challenge. Commonly defined by the Nova system, UPFs are industrially processed products made with additives…
Ultraprocessed foods and beverages (UPFs) pose a growing public health challenge. Commonly defined by the Nova system, UPFs are industrially processed products made with additives…
BACKGROUND: Renal fibrosis plays a key role in the progression of diabetic kidney disease (DKD). Although the renal protective effects of NPs (natriuretic peptides) were…
BACKGROUND: In the aftermath of intracerebral hemorrhage (ICH), the clearance of harmful substances from the hematoma helps to mitigate brain edema and reduce the risk…
BackgroundDisease‐causative variants in LMNA‐encoded lamin A/C cause a genetic cardiomyopathy characterized by atrioventricular block, atrial fibrillation, ventricular arrhythmias, and systolic dys…
Stroke disproportionately affects individuals from culturally and linguistically diverse backgrounds, often leading to poorer outcomes. Although stroke guidelines are essential for ensuring evidence-based care, the…
Large vessel occlusion (LVO) in the setting of intracranial atherosclerotic disease accounts for approximately 10% to 48% of all LVO strokes. 1 Although this patient…
Spending on glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in the United States increased over 500% from $13.7 billion in 2018 to $71.7 billion in 2023.…
Ultraprocessed foods and beverages (UPFs) pose a growing public health challenge. Commonly defined by the Nova system, UPFs are industrially processed products made with additives…
